Clinical Research Directory
Browse clinical research sites, groups, and studies.
Brain Imaging Biomarkers in Patients With Brain Metastasis
Sponsor: University Health Network, Toronto
Summary
A biomarker is a measurable indicator of the severity or presence of some disease state. In this study, brain metastases patients who will be receiving radiation treatment, will undergo CT (Computed Tomography) and MRI (Magnetic Resonance Imaging) scans prior to and after radiation treatment to measure these biomarkers. This is a single-center phase II study to validate the predictive abilities of biomarkers, in terms of determining how patients will respond to radiation treatment.
Official title: Imaging Trial of Biomarkers to Guide Individualized Therapy in Patients With Brain Metastasis Receiving Radiotherapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2021-10-05
Completion Date
2027-06
Last Updated
2026-03-05
Healthy Volunteers
No
Conditions
Interventions
CT and MRI Scans
CT and MRI scans will occur before and after radiation therapy.
Locations (1)
University Health Network
Toronto, Ontario, Canada